Virtus Biotech ETF
12 hedge funds and large institutions have $7.13M invested in Virtus Biotech ETF in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
4.01% more ownership
Funds ownership: 32.44% → 36.46% (+4%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4% less capital invested
Capital invested by funds: $7.43M → $7.13M (-$305K)
8% less funds holding
Funds holding: 13 → 12 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$575K |
| 2 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$138K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.4K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
+$2.73K |
| 5 |
Morgan Stanley
New York
|
+$895 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
-$389K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$175K |
| 3 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$59.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$46K |
| 5 |
SMG
Smart Money Group
Eastland,
Texas
|
-$41.1K |
BBP Hedge Fund Activity: Q4 2021 in Review
12 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2021, worth a combined $7.13M — down 4.1% from $7.43M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BBP and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Susquehanna International Group, adding an estimated $575K. The largest seller was Stifel Financial, exiting entirely with an estimated $389K sold.
- 12 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2021, down from 13 in Q3 2021.
- Funds reported $7.13M of Virtus Biotech ETF stock for Q4 2021, down 4.1% quarter-over-quarter.
- 2 funds opened new Virtus Biotech ETF positions in Q4 2021 and 3 closed out, a net change of -1 holder.
- The largest Virtus Biotech ETF buyer in Q4 2021 was Susquehanna International Group, an estimated $575K added.
- The largest Virtus Biotech ETF seller in Q4 2021 was Stifel Financial, an estimated $389K sold.
Based on aggregated 13F filings for Q4 2021.